Xtant Medical Holdings, Inc.
XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31
Reports and events: 545 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-09-1911:03 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-18-000751 |
| 2018-09-1707:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-013320 |
| 2018-08-2016:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-012342 |
| 2018-08-0816:18 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001493152-18-011170 |
| 2018-08-0717:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-18-011100 |
| 2018-08-0316:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-18-010957 |
| 2018-07-1006:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-009846 |
| 2018-06-2607:43 ET | DEF 14A | Proxy statementPeriod 2018-06-26 | 0001493152-18-009197 |
| 2018-06-1908:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-18-008885 |
| 2018-05-3016:22 ET | S-1/A | Registration statement, amended | 0001144204-18-031665 |
| 2018-05-2107:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-18-029946 |
| 2018-05-1816:26 ET | 8-K | 8.01 Other events | 0001144204-18-029837 |
| 2018-05-1616:17 ET | S-1/A | Registration statement, amended | 0001144204-18-029220 |
| 2018-05-1516:19 ET | S-1 | Registration statement | 0001144204-18-028900 |
| 2018-05-0816:39 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001144204-18-026164 |
| 2018-04-1819:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-021015 |
| 2018-04-1819:12 ET | S-1/A | Registration statement, amended | 0001144204-18-021010 |
| 2018-04-0515:06 ET | 10-K/A | Annual report, amendedPeriod 2017-12-31 | 0001144204-18-019363 |
| 2018-04-0306:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-18-018804 |
| 2018-04-0217:28 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001144204-18-018725 |
| 2018-03-3017:26 ET | 10-Q/A | Quarterly report, amendedPeriod 2017-06-30 | 0001144204-18-018329 |
| 2018-03-3017:25 ET | 10-Q/A | Quarterly report, amendedPeriod 2017-03-31 | 0001144204-18-018327 |
| 2018-03-2707:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-017015 |
| 2018-02-1616:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-009541 |
| 2018-02-1516:30 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-18-000155 |
| 2018-02-1507:00 ET | 8-K | 8.01 Other events | 0001144204-18-009155 |
| 2018-02-1317:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-008047 |
| 2018-02-0717:30 ET | S-1 | Registration statement | 0001144204-18-006371 |
| 2018-01-3112:48 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-18-004833 |
| 2018-01-2310:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-18-003172 |
| 2018-01-2214:24 ET | DEF 14A | Proxy statementPeriod 2018-02-13 | 0001144204-18-003037 |
| 2018-01-1811:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-18-002596 |
| 2018-01-1717:19 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-18-000043 |
| 2018-01-1221:50 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001144204-18-001982 |
| 2018-01-0215:36 ET | 8-K | 5.07 Shareholder vote results | 0001144204-18-000194 |
| 2017-12-2916:49 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-065910 |
| 2017-12-0815:13 ET | DEF 14A | Proxy statementPeriod 2017-12-29 | 0001144204-17-062947 |
| 2017-12-0408:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-062064 |
| 2017-11-2116:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-17-060445 |
| 2017-11-2108:49 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001144204-17-060277 |
| 2017-11-2017:16 ET | 8-K | 4.02 Non-reliance on financial statements | 0001144204-17-060210 |
| 2017-11-1416:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-059058 |
| 2017-11-0907:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-17-057434 |
| 2017-11-0614:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-17-056465 |
| 2017-10-3116:48 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-055181 |
| 2017-10-3118:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000593 |
| 2017-10-2516:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000581 |
| 2017-10-0611:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001552781-17-000541 |
| 2017-10-0309:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-051060 |
| 2017-09-1408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000524 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.